Press Releases MFX appoints Dr. Katy Newton as Chief Scientific Officer to drive innovation for cell-based therapies 18 March 2025 MFX, Tolemy Bio and Aminoacids.com partner to deliver model-driven media optimization for cell and gene therapies 05 December 2024 MFX secures Innovate UK award to advance high throughput stackable bioreactor platform for cell and gene therapies 19 December 2023 MFX welcomes new board members and scientific advisor 28 September 2023 Anthony Nolan announces partnership with bioprocessing innovator MFX 19 June 2023 MFX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies 2 May 2023 MicrofluidX and CCRM partner on end-to-end bioprocessing of CAR-T cell therapies 11 January 2023 MFX raises £3.3 million to develop their next generation advanced therapy manufacturing platform 8 December 2022 MicrofluidX and Stemmatters partner on advancing automated 2D expansion of Mesenchymal Stem Cells for cell therapy 26 October 2022 MicrofluidX and Stemmatters partner on advancing automated 2D expansion of Mesenchymal Stem Cells for cell therapy 26 October 2022
